PRUITT MICHAEL D (CEO, Chairman) purchased 7.1% of their position (2.17K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $1.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/19/2019ACC: 0001493152-19-017947
DirectorOfficer· CEO, Chairman
Since Aug 2018
+3.17K
Net shares
Net buyer
$1.6K
Total acquired
3
Open market trades
3B · 0S
4
Total transactions
3.17K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+165.00
Price / share
$0.64
Trade value
$106.05
% of position
3.5%
11/17/2019
4.69K→4.86K
Common Stock
Indirect
Shares
+500.00
Price / share
$0.75
Trade value
$375.00
% of position
11.1%
11/19/2019
4.52K→5.02K
Common Stock
Indirect
Shares
+1K
Price / share
$0.05
Trade value
$50.00
% of position
3.1%
11/19/2019
32.46K→33.46K
Common Stock
Indirect
Shares
+1.50K
Price / share
$0.69
Trade value
$1.03K
% of position
4.8%
11/19/2019
30.96K→32.46K
Total
Net shares
+3.17K
Net value
$1.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/17/2019 | P · Purchase | +165.00 | $0.64 | $106.05 | 3.5% | 4.69K | 4.86K |
| Common Stock Indirect | 11/19/2019 | P · Purchase | +500.00 | $0.75 | $375.00 | 11.1% | 4.52K | 5.02K |
| Common Stock Indirect | 11/19/2019 | C · Conversion | +1K | $0.05 | $50.00 | 3.1% | 32.46K | 33.46K |
| Common Stock Indirect | 11/19/2019 | P · Purchase | +1.50K | $0.69 | $1.03K | 4.8% | 30.96K | 32.46K |
| Total | +3.17K | $1.57K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Series 1 Preferred Stock
IndirectShares owned340.00
Common Stock
DirectShares owned17.26K
Total
17.26K direct·340.00 indirect17.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series 1 Preferred Stock | 340.00 | Indirect |
| Common Stock | 17.26K | Direct |
| Total | 17.60K | 17.26K direct·340.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported